135 related articles for article (PubMed ID: 36696641)
1. Superficial dyspareunia treatment with hyperstacking of erbium:yttrium-aluminum-garnet SMOOTH laser: a short-term, pilot study in breast cancer survivors.
Fidecicchi T; Gaspar A; Gambacciani M
Menopause; 2023 Feb; 30(2):174-178. PubMed ID: 36696641
[TBL] [Abstract][Full Text] [Related]
2. Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study.
Gambacciani M; Fidecicchi T
Climacteric; 2022 Apr; 25(2):208-211. PubMed ID: 35006008
[TBL] [Abstract][Full Text] [Related]
3. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors.
Gambacciani M; Levancini M
Menopause; 2017 Mar; 24(3):316-319. PubMed ID: 28231079
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Two Laser Treatment Strategies for Breast Cancer Survivors With Genitourinary Syndrome of Menopause.
Okui N; Okui M; Kouno Y; Nakano K; Gambacciani M
Cureus; 2023 May; 15(5):e38604. PubMed ID: 37284382
[TBL] [Abstract][Full Text] [Related]
6. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
Gambacciani M; Levancini M; Cervigni M
Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
[TBL] [Abstract][Full Text] [Related]
7. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause.
Gambacciani M; Levancini M
Minerva Ginecol; 2015 Apr; 67(2):97-102. PubMed ID: 25763800
[TBL] [Abstract][Full Text] [Related]
8. Genitourinary syndrome of menopause (GSM) and laser VEL: a review.
Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E
Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563
[TBL] [Abstract][Full Text] [Related]
9. The effect of vaginal erbium laser treatment on sexual function and vaginal health in women with a history of breast cancer and symptoms of the genitourinary syndrome of menopause: a prospective study.
Arêas F; Valadares ALR; Conde DM; Costa-Paiva L
Menopause; 2019 Sep; 26(9):1052-1058. PubMed ID: 31453969
[TBL] [Abstract][Full Text] [Related]
10. Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study.
Gambacciani M; Albertin E; Torelli MG; Bracco GL; Casagrande AC; Martella L; Baiocchi G; Alfieri S; Russo N; Cervigni M;
Climacteric; 2020; 23(sup1):S24-S27. PubMed ID: 33124454
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
12. Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment.
Mothes AR; Runnebaum M; Runnebaum IB
J Cancer Res Clin Oncol; 2018 May; 144(5):955-960. PubMed ID: 29487993
[TBL] [Abstract][Full Text] [Related]
13. Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial.
Mension E; Alonso I; Anglès-Acedo S; Ros C; Otero J; Villarino Á; Farré R; Saco A; Vega N; Castrejón N; Ordi J; Rakislova N; Tortajada M; Matas I; Gómez S; Ribera L; Castelo-Branco C
JAMA Netw Open; 2023 Feb; 6(2):e2255697. PubMed ID: 36763359
[TBL] [Abstract][Full Text] [Related]
14. Female urine incontinence:
Elia D; Gambiacciani M; Ayoubi JM; Berreni N; Bohbot JM; Descamps P; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E
Horm Mol Biol Clin Investig; 2020 Oct; 41(4):. PubMed ID: 33119542
[TBL] [Abstract][Full Text] [Related]
15. Effect of Er:YAG Laser for Women with Stress Urinary Incontinence.
Lin KL; Chou SH; Long CY
Biomed Res Int; 2019; 2019():7915813. PubMed ID: 30766886
[TBL] [Abstract][Full Text] [Related]
16. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
[TBL] [Abstract][Full Text] [Related]
17. Sexual Function in Women Suffering From Genitourinary Syndrome of Menopause Treated With Fractionated CO
Salvatore S; Pitsouni E; Del Deo F; Parma M; Athanasiou S; Candiani M
Sex Med Rev; 2017 Oct; 5(4):486-494. PubMed ID: 28843942
[TBL] [Abstract][Full Text] [Related]
18. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study.
Gaspar A; Maestri S; Silva J; Brandi H; Luque D; Koron N; Vižintin Z
Lasers Surg Med; 2018 Oct; 50(8):802-807. PubMed ID: 29667744
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.
Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M
Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800
[TBL] [Abstract][Full Text] [Related]
20. Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors.
Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Suresh A; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Smith KL; Faubion SS; Loprinzi CL; Lustberg MB
Support Care Cancer; 2020 Aug; 28(8):3669-3677. PubMed ID: 31811486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
